Annual costs of stroke in US children at least $42 million

Jul 09, 2009

Stroke in children costs at least $42 million annually in the United States, researchers report in Stroke: Journal of the American Heart Association.

In the first cost analysis of pediatric stroke in the United States, researchers reviewed data from U.S. children age 0 to 20 who used hospital inpatient services. The database, the Kid's Inpatient Database (KID 2003), recorded 2,224 strokes.

"This is just the upfront cost — the initial stroke care of these children — not the long-term care cost," said Warren Lo, M.D., lead author of the study and associate professor of pediatrics and neurology at The Ohio State University and pediatric neurologist at Nationwide Children's Hospital in Columbus, Ohio.

Many other expenses will arise for those caring for a child recovering from a stroke, including transportation and lodging near a hospital with the capability to treat pediatric stroke; rehabilitation, if necessary; and missed time from work for caregivers.

"It's expensive for a kid to have a stroke," Lo said. "We must find more effective treatment — earlier, better treatment — that can reduce cost for kids staying in hospitals."

The study found:

  • Acute treatment results in an average hospital stay of 8.3 days, costing almost $21,000.
  • Strokes characterized by bleeding between the brain and skull (subarachnoid hemorrhage) resulted in an 11.2-day hospital stay and cost a average of more than $31,000.
  • The hospital stay for bleeding inside the brain (intracerebral hemorrhage) averaged 9.6 days and cost an average of more than $24,000.
  • (caused by a blockage in a blood vessel in or leading to the brain) averaged a 6.6 day stay and $15,000 in costs.
Costs were higher at government/public hospitals and urban teaching hospitals. Also, costs were highest in the western and lowest in the South, researchers said.

Of the total, 22 percent were subarachnoid hemorrhage, 23 percent were intracerebral hemorrhage and 55 were ischemic stroke.

In adults, roughly 13 percent of all U.S. strokes are the bleeding type, according to the American Heart Association/American Stroke Association. However, in this study, the bleeding type accounted for almost 45 percent in children.

Of the cases, private insurance covered 55 percent of the children, Medicaid or Medicare government insurance programs covered 35 percent and self-pay or other coverage accounted for the remaining 10 percent. The study also found that for families with the higher incomes, childhood costs were greater.

Furthermore, boys had more hemorrhages, while girls had more ischemic strokes. The strokes occurred most often in children ages 15 to 20 years old — but the reasons for this were not clear.

Researchers calculated actual pay in 2003 dollars for hospital services after discounts were applied and didn't include doctor fees that may have been billed separately. Researchers said it was difficult to directly compare to studies of adults; however, the magnitude of the costs are similar.

Source: American Heart Association (news : web)

Explore further: 'Ebola will return', veteran scientist warns

Related Stories

Blood-Thinning Drug Linked to Increased Bleeding in Brain

Sep 29, 2008

(PhysOrg.com) -- Patients who take the commonly used blood-thinning drug warfarin face larger amounts of bleeding in the brain and increased risk of mortality if they suffer a hemorrhagic stroke, new research from the University ...

Cholesterol-lowering drugs and the risk of hemorrhagic stroke

Dec 12, 2007

People taking cholesterol-lowering drugs such as atorvastatin after a stroke may be at an increased risk of hemorrhagic stroke, or bleeding in the brain, a risk not found in patients taking statins who have never had a stroke. ...

Arrival method, slow response often delay stroke care

Aug 08, 2008

Most stroke patients can't recall when their symptoms started or do not arrive at the hospital in a timely manner, so they cannot be considered for time-dependent therapies such as the clot-busting drug tissue plasminogen ...

Recommended for you

'Ebola will return', veteran scientist warns

6 hours ago

Congolese expert Jean-Jacques Muyembe may be little known to the public, but he has been one of the world's top Ebola investigators since the first epidemic erupted in central Africa in 1976.

Score IDs patients with upper extremity DVT at low risk

21 hours ago

(HealthDay)—For patients with upper-extremity deep vein thrombosis (DVT), six easily available factors can be used to create a score that identifies those at low risk of adverse events during the first ...

Combined drug treatment combats kidney disease

May 29, 2015

A recent discovery by drug researchers whereby coupling specific cell membrane receptors has altered kidney cell function has triggered a re-think of how to treat chronic kidney disease (CKD) more effectively.

Active substance targeting dreaded hospital germs

May 29, 2015

In the German Center for Infection Research (DZIF), scientists have conducted clinical studies on an active substance against the dreaded hospital pathogen Staphylococcus aureus: a highly effective protein from bacteriophages ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.